Tiziana Life Sciences (NASDAQ: TLSA) is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and lung diseases.
FDA Clears IND to Test Intranasal Foralumab in Alzheimer Disease Aug 15, 2023 Isabella Ciccone, MPH Foralumab, a therapy designed to bind to T. -Today at 07:53 am- MarketScreener
US officials have granted full approval to Leqembi, the first medication to demonstrate modest effectiveness in slowing cognitive decline associated with.
Tiziana Life Sciences Chief Medical Officer Dr. Matthew Davis joins Natalie Stoberman from the Proactive newsroom to share how the company is planning to.
Tiziana Life Sciences Chief Medical Officer Dr. Matthew Davis joins Natalie Stoberman from the Proactive newsroom to explain how the company is pursuing the.